BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3432BiotechnologyAI medical concept stocks
$11.47 −$0.94 (-7.57%)
Pre-market · Oct 8, 8:20 am ET · After hours $11.31 -1.40%
Open$11.81
Prev close$12.41
Day range$10.81 – $11.95
Volume6.46M
Market cap$772.39M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong uptrend

7 bullish · 0 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average+17.0%BullishTrading above the 20-day average of $9.81
Price vs 50-day average+36.5%BullishTrading above the 50-day average of $8.40
Price vs 200-day average+36.7%BullishTrading above the 200-day average of $8.39
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)57.4BullishMomentum leans positive
MACD (12,26,9)1.42BullishMACD line is above its signal line
Bollinger band position67%BullishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$9.81+17.0%
50-day SMA$8.40+36.5%
200-day SMA$8.39+36.7%

Recent price levels

LevelPrice
20-day high$18.22
20-day low$6.52
60-day high$18.22
60-day low$6.47
Upper Bollinger band$14.82
Lower Bollinger band$4.79

The 50-day average is currently 0.1% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility125.7%
Average true range15.14% of price
Max drawdown (1y)-66.0%
Volume (10d vs 90d)3.04x

Discussion

No comments yet — be the first to weigh in on DNA.

Leave a comment

Scroll to Top